Skip to main content
Year archive

Xvivo Perfusion — 2019 filings

All 34 regulatory filings released by Xvivo Perfusion (XVIVO) in 2019, sourced directly from the official regulator.

34 Filings
2019 Period
2019 filings (34)
Filing Released Lang
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-10-24 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-10-24 English
XVIVO Perfusion AB (publ) issue of warrants of series 2019/2021 fully subscribed
Share Issue/Capital Change
2019-10-23 English
XVIVO Perfusion AB (publ) teckningsoptioner av serie 2019/2021 fulltecknat
Capital/Financing Update
2019-10-23 Swedish
Perfadex Plus har erhållit patentgodkännande i Europa
Regulatory Filings
2019-08-21 Swedish
Perfadex® Plus has received patent approval in Europe
Regulatory Filings
2019-08-21 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-07-12 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-07-12 English
XVIVO Perfusion changes the date of reporting of the Report on Operations 2019 to January 30, 2020
Report Publication Announcement
2019-06-25 English
XVIVO Perfusion tidigarelägger datum för rapportering av Bokslutskommuniké 2019 till den 30:e januari 2020.
Report Publication Announcement
2019-06-25 Swedish
Change in number of shares and votes in XVIVO Perfusion
Declaration of Voting Results & Voting Rights Announcements
2019-05-31 English
Förändring av antalet aktier och röster i XVIVO Perfusion
Share Issue/Capital Change
2019-05-31 Swedish
XVIVO har erhållit klartecken från läkemedelsverket för kliniska studier med bolagets nya produkter för hjärtpreservation
Legal Proceedings Report
2019-05-15 Swedish
XVIVO has received approval from the Swedish MPA to begin clinical studies with the company's new products for heart preservation
Regulatory Filings
2019-05-15 English
First XPS™ sold to Canada
Regulatory Filings
2019-05-03 English
Första XPS™ såld till Kanada
Regulatory Filings
2019-05-03 Swedish
XVIVOs patent för hjärtpreservations-vätska godkända i USA och Europa
Regulatory Filings
2019-05-02 Swedish
XVIVO’s patents for the heart preservation fluid approved in the US and Europe
Regulatory Filings
2019-05-02 English
XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™
Regulatory Filings
2019-04-27 English
XVIVO har erhållit marknadsgodkännande (PMA) för STEEN Solution™ och XPS™ av FDA
Regulatory Filings
2019-04-27 Swedish
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2019-04-25 Swedish
Report from Annual general meeting of XVIVO Perfusion AB (publ)
AGM Information
2019-04-25 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-24 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-04-24 English
Annual Report 2018
Annual Report FY 2018
2019-04-02 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-02 English
AMENDMENT OF NOTICE TO ATTEND ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (publ)
AGM Information
2019-03-25 English
RÄTTELSE AV KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (publ)
AGM Information
2019-03-25 Swedish
Annual General Meeting of XVIVO Perfusion AB (publ)
AGM Information
2019-03-20 English
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2019-03-20 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-08 Swedish
Earnings Release 2018
Earnings Release FY 2018
2019-02-08 English
Information från XVIVO Perfusions Valberedning
Board/Management Information
2019-01-15 Swedish
Information from XVIVO Perfusion´s Nomination Committee
Board/Management Information
2019-01-15 English